AFC-HD AMS Life Science Co., Ltd. (TYO:2927)
905.00
+3.00 (0.33%)
Feb 16, 2026, 3:30 PM JST
AFC-HD AMS Life Science Balance Sheet
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Cash & Equivalents | 10,603 | 11,303 | 12,172 | 11,182 | 10,377 | 9,222 |
Cash & Short-Term Investments | 10,603 | 11,303 | 12,172 | 11,182 | 10,377 | 9,222 |
Cash Growth | -7.27% | -7.14% | 8.85% | 7.76% | 12.52% | 95.17% |
Receivables | 3,536 | 2,915 | 2,792 | 2,828 | 2,563 | 2,184 |
Inventory | 6,908 | 7,022 | 5,981 | 4,362 | 3,728 | 3,851 |
Other Current Assets | 1,234 | 1,085 | 1,149 | 1,503 | 457 | 595 |
Total Current Assets | 22,281 | 22,325 | 22,094 | 19,875 | 17,125 | 15,852 |
Property, Plant & Equipment | 22,021 | 21,335 | 19,416 | 17,144 | 15,922 | 16,011 |
Long-Term Investments | 2,892 | 2,876 | 2,857 | 2,558 | 2,808 | 2,115 |
Goodwill | 1,806 | 1,870 | 2,349 | 1,289 | 1,338 | 1,491 |
Other Intangible Assets | 147 | 148 | 167 | 92 | 118 | 161 |
Long-Term Deferred Tax Assets | - | 170 | 146 | 112 | 35 | 120 |
Other Long-Term Assets | 1 | 2 | 1 | 1 | 2 | 2 |
Total Assets | 49,148 | 48,726 | 47,030 | 41,071 | 37,348 | 35,752 |
Accounts Payable | 3,768 | 3,623 | 3,586 | 3,265 | 3,414 | 2,966 |
Accrued Expenses | 265 | 197 | 188 | 170 | 152 | 196 |
Short-Term Debt | 9,543 | 9,472 | 9,078 | 7,914 | 6,816 | 3,962 |
Current Portion of Long-Term Debt | 8,962 | 8,964 | 519 | 303 | 182 | 1,027 |
Current Income Taxes Payable | 290 | 475 | 506 | 368 | 175 | 646 |
Other Current Liabilities | 3,142 | 3,261 | 3,745 | 2,834 | 2,479 | 3,005 |
Total Current Liabilities | 25,970 | 25,992 | 17,622 | 14,854 | 13,218 | 11,802 |
Long-Term Debt | 5,370 | 5,475 | 13,293 | 11,319 | 10,136 | 9,691 |
Pension & Post-Retirement Benefits | 1,016 | 1,013 | 1,022 | 991 | 1,000 | 974 |
Long-Term Deferred Tax Liabilities | - | 215 | 229 | 258 | 265 | 298 |
Other Long-Term Liabilities | 1,113 | 833 | 908 | 493 | 285 | 327 |
Total Liabilities | 33,469 | 33,528 | 33,074 | 27,915 | 24,904 | 23,092 |
Common Stock | 2,152 | 2,134 | 2,131 | 2,131 | 2,131 | 2,131 |
Additional Paid-In Capital | 2,653 | 2,651 | 2,650 | 2,638 | 2,640 | 2,438 |
Retained Earnings | 10,707 | 10,427 | 9,415 | 8,589 | 7,880 | 7,420 |
Treasury Stock | -86 | -255 | -275 | -353 | -305 | -141 |
Comprehensive Income & Other | 129 | 118 | 11 | 103 | 92 | 69 |
Total Common Equity | 15,555 | 15,075 | 13,932 | 13,108 | 12,438 | 11,917 |
Minority Interest | 124 | 123 | 24 | 48 | 6 | 743 |
Shareholders' Equity | 15,679 | 15,198 | 13,956 | 13,156 | 12,444 | 12,660 |
Total Liabilities & Equity | 49,148 | 48,726 | 47,030 | 41,071 | 37,348 | 35,752 |
Total Debt | 23,875 | 23,911 | 22,890 | 19,536 | 17,134 | 14,680 |
Net Cash (Debt) | -13,272 | -12,608 | -10,718 | -8,354 | -6,757 | -5,458 |
Net Cash Per Share | -940.65 | -896.23 | -762.76 | -594.48 | -478.56 | -387.93 |
Filing Date Shares Outstanding | 14.31 | 14.09 | 14.06 | 13.97 | 14.04 | 14.19 |
Total Common Shares Outstanding | 14.31 | 14.09 | 14.06 | 13.97 | 14.04 | 14.19 |
Working Capital | -3,689 | -3,667 | 4,472 | 5,021 | 3,907 | 4,050 |
Book Value Per Share | 1087.03 | 1069.82 | 990.63 | 938.19 | 886.21 | 839.75 |
Tangible Book Value | 13,602 | 13,057 | 11,416 | 11,727 | 10,982 | 10,265 |
Tangible Book Value Per Share | 950.55 | 926.61 | 811.73 | 839.35 | 782.47 | 723.34 |
Order Backlog | - | 1,014 | 933.61 | 891.23 | 718.94 | 714.19 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.